INTRODUCTION
Benzoimidazole derivatives have been found to possess various biological activities. [1] [2] [3] We have recently started a program of the synthesis of heterocyclic compounds including pyridine and thienopyridine derivatives. 4, 5 Within our ongoing program, we intend to extend the existing synthetic route using 2-acetylbenzoimidazol 1 as the key compound in the synthesis of some new heterocycles with potential biological activity.
RESULTS AND DISCUSSION
The key precursor 2-acetylbenzoimidazole 1 6 was reacted with arylaldehydes to afford chalcone analogues 2. 7, 8 Treatment of 2 with equimolar amounts of 2-amino-2-methylacrilonitrile in refluxing glacial acetic acid afforded the corresponding 4-aryl-6-(1H-benzoimidazol-2-yl)-2-methyl-1,4-dihydropyridine-3-carbonitrile (3a-c) in acceptable yields, Scheme 1. Structure of compounds 3a-c was elucidated by analytical and spectroscopic data. Thus, the IR (KBr) spectra of 3a showed broad absorption bands at 3386-3332 (NH) and 2221 cm -1 (CºN) and its 1 H NMR spectrum showed a doublet signal at d = 4.6 ppm (1H) attributed to H-4 pyridine, besides other expected signals. Also, its mass spectrum revealed a molecular ion peak at m/z = 342 (23 %) corresponding to the molecular formula C 21 H 18 N 4 O. Alternatively, refluxing of equimolar amounts of each 2a-d and cyanothioacetamide in ethanol, in the presence of a catalytic amount of piperidine, afforded 4-aryl-6-(benzoimidazol-2-yl)-2-mercaptopyridine-3-carbonitrile 7a-d. Compound 7 is assumed to be formed via initial Michael adduct 4 followed by intramolecular cyclodehydration and spontaneous autoxidation under the reaction conditions. 9,10 Although cyclization of 4 to 2-aminothiopyran derivative 5 is also possible, we did not observe formation of this product. The structure of 7 was assigned to the isolated products 7a-d on the basis of elemental analysis, IR and in particular 1 H NMR spectra; the latter revealed the absence of H-4 in the thiopyran unit.
An approach starting from 7a-c the synthesis of 3-amino-4-aryl-6-(1H-benzoimidazol-2-yl)thieno [2,3-b] pyridines 10a-d through their condensation with active halomethylene compounds 8a,b, in boiling ethanol in the presence of sodium ethoxide, was studied, Scheme 2. This reaction presumably occurred through intermediate 9, which was obtained when the less basic catalyst sodium acetate was used. The structure of compounds 10a-d was confirmed on the basis of their correct elemental analyses as well as compatible spectral data. Condensation of compounds 10a,c with formamide afforded 4-aryl-2-(1H-benzoimidazol-2-yl)-7H-pyrido[2,3:4',5']thieno[3,2-d]pyrimidin-8-one 11a,b, respectively. The structure of compounds 11a,b was elucidated by analytical and spectroscopic data. Thus, the IR spectra of 11a,b revealed the absence of (NH 2 ) function, and showed absorption bands at 3440 (NH) and 1705-1689 cm -1 (CO). The mass spectrum of 11b showed the molecular ion peak m/z = 396 (23 %) corresponding to the molecular formula C 21 H 12 N 6 OS.
The reaction of heterocyclic amines and aromatic a,b-unsaturated ketones is a very convenient and versatile method for fusion of a pyridine ring in polycyclic heterocycles. 13, 14 Nucleophilic amines 12a,b can attack the carbonyl carbon atom C1 or C3 of the ketones 2. Actually, only the first attack takes places and the corresponding 14a-e or 17a,b were isolated.
Reaction of equimolar amounts of a mixture of 2 and 12 in DMF for 6-8 hours gave pyrido [2,3- dines 14a-e. These compounds and their oxo and thioxo derivatives reveal interesting biological and physiological properties. 11, 12 The structure of 14a-e was deduced from their analytical and spectral data. Thus, their IR spectra showed absorption bands at 3433-3180 (NH), 1720-1687 cm -1 (amide CO Finally, on heating 1 with arylaldehydes 18a-c in the 2:1 mole ratio in the presence of NH 4 OAc, 15 4-aryl-2,6-bis(benzoimidazol-2-yl)pyridine (20a-c) were isolated in good yield. The structure of these symmetric compounds was elucidated from the IR spectra showing absorption bands at 3425-3255 cm -1 (NH); the 1 H NMR (DMSO-d 6 ) spectrum of 20b showed, in addition to the expected signals, a singlet at d = 3.91 ppm assigned to OCH 3 . Also, the mass spectrum of 20b showed the molecular ion peak m/z = 417 (100 %) corresponding to the molecular formula C 26 H 19 N 5 O. Reaction of 1 with arylaldehydes 18b,c in a 2:1 mole ratio in aqueous ethanolic NaOH solution afforded the intermediary acyclic 3-aryl-1,5-bis(benzoimidazol-2-yl)pentan-1,5-diones 19a,b which underwent a facile ring closure in the presence of NH 4 OAc to give products 20b,c, Scheme 4.
EXPERIMENTAL
Melting points were uncorrected, determined in glass capillary tubes on a MEL-TEMP II melting point apparatus. Infrared spectra were recorded with a Shimadzu FTR-8201 PC spectrophotometer. 1 H NMR were obtained on a Varian Gemini (200 MHz) spectrometer using DMSO-d 6 and/or CDCl 3 -d 1 as solvent and TMS as internal reference. Mass spectra were performed on a Shimadzu GCMS -QP 1000EX spectrometer using a direct inlet system and EI-QI MS LRUPL. Microanalysis was performed by the Microanalytical Unit at the Cairo University. Thin layer chromatogra- phy was carried out on 5´20 cm plates coated with silica gel GF 254 type 60, mesh size 50-250. Compounds 1 (8) and 2 (9, 10) were prepared according to the reported method.
4-Aryl-6-(1H-benzoimidazol-2-yl)-2-methyl-1,4-dihydropyridine-3-carbonitrile (3a-c)
General Procedure. -To a solution of compound 2 (1.0 mmol) in acetic acid (10 mL), 2-amino-2-methyl acrylonitrile (1.0 mmol) was added. The reaction mixture was heated under reflux for 6 hours. After cooling, the solid obtained was collected by filtration and recrystallized from ethanol. 
6-(1H-Benzoimidazol-2-yl)-2-methyl-4-(4-methoxyphenyl)-

Preparation of 7a-d
General Procedure. -To a solution of 2 (5.0 mmol) in ethanol (30 mL) containing a few drops of piperidine, cyanothioacetamide (5.0 mmol) was added. The mixture was heated under reflux for 6 hours and cooled; the precipitate formed was filtered off and recrystallized from a proper solvent. 
6-(1H-Benzoimidazol-2-yl)-2-mercapto-4-(4-methoxyphenyl)-1,4-dihydropyridine-3-carbonitrile (7a)
.
6-(1H-Benzoimidazol-2-yl)-2-mercapto-4-(4-chlorophenyl)-1,4-dihydropyridine-3-carbonitrile (7b
6-(1H-Benzoimidazol-2-yl)-2-mercapto-4-(3-pyridyl)-1,4-dihydropyridine-3-carbonitrile (7c)
6-(1H-Benzoimidazol-2-yl)-2-mercapto-4-(4-nitrophenyl)-1,4-dihydropyridine-3-carbonitrile (7d)
4-Aryl-[6-(1H-benzoimidazol-2-yl)-3-cyanopyridin-2-sulfanyl] derivatives (9a-b)
General Procedure. -Compound 7a,c (2.0 mmol) was dissolved in ethanolic solution of sodium acetate (20 mL, 20 %). Then the appropriate alkylating agent 8a,b (2.0 mmol) was added and the mixture was heated under reflux for 30 min. After cooling, the mixture was poured onto cold water (80 mL), the precipitate was collected by filtration and recrystallized from a proper solvent. 
Preparation of 10a-d
To compound 7 (2.0 mmol) in ethanolic sodium ethoxide solution (25 ml EtOH, 0.1 g Na), an alkylating agent (2.0 mmol) was added. The reaction mixture was heated under reflux for 4 hours. After cooling, the mixture was poured onto cold water (75 mL) and the solid product was filtered and recrystallized from benzene. [2,3-b] 
3-Amino-6-(1H-benzoimidazol-2-yl)-4-(4-methoxyphenyl)-thieno[2,3-b]pyridine-2-carboxylic acid ethyl ester (10a)
3-Amino-6-(1H-benzoimidazol-2-yl)-4-(4-chlorophenyl)thieno[2,3-b]pyridine-2-phenylmethanone (10b
3-Amino-6-(1H-benzoimidazol-2-yl)-4-(3-pyridyl)thieno
4-Aryl-2-(1H-benzoimidazol-2-yl)-7H-pyrido[2,3:4',5']-thieno[3',2'-d]pyrimidin-8-one (11a,b)
General Procedure. -Compound 10a,c (1.0 mmol) in formamide (10 mL) was heated under reflux for 6 h. The mixture was cooled, diluted with water (40 mL) and the resulting precipitate was collected and recrystallized from DMF. 
2-(1H-Benzoimidazol-2-yl)-4-(4-methoxyphenyl)-7H-pyrido-
Preparation of 14a-e
General Procedure. -To a solution of appropriate 2 (2.0 mmol) in DMF (30 mL) containing a few drops of piperidine, 6-aminouracile or 6-aminothiouracile 12a,b (2.0 mmol) was added. The reaction mixture was heated under reflux for 6-8 hours. After cooling, the precipitate was collected by filtration and recrystallized from DMF/EtOH. [2,3- 
7-(1H-Benzoimidazol-2-yl)-5-(4-methoxyphenyl)-5,8-dihydro-1H-pyrido
